Cargando…
Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells
Triple negative breast cancers (TNBCs) do not respond to conventional estrogen receptor/progesterone receptor/human epidermal growth factor receptor-2 targeted interventions due to the absence of the respective receptor targets. They are aggressive, exhibit early recurrence, metastasize, are more in...
Autores principales: | Varghese, Elizabeth, Samuel, Samson Mathews, Varghese, Sharon, Cheema, Sohaila, Mamtani, Ravinder, Büsselberg, Dietrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315979/ https://www.ncbi.nlm.nih.gov/pubmed/30563138 http://dx.doi.org/10.3390/biom8040163 |
Ejemplares similares
-
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
por: Varghese, Elizabeth, et al.
Publicado: (2018) -
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
por: Varghese, Sharon, et al.
Publicado: (2019) -
Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model
por: Huang, Zhaoming, et al.
Publicado: (2020) -
Potential Effects of Chrysin on MDA-MB-231 Cells
por: Hong, Teh Ban, et al.
Publicado: (2010) -
Effects of FSTL1 on cell proliferation in breast cancer cell line MDA-MB-231 and its brain metastatic variant MDA-MB-231-BR
por: An, Jiaqiang, et al.
Publicado: (2017)